| http://dbpedia.org/ontology/abstract
|
GSK2831781 is a monoclonal antibody being … GSK2831781 is a monoclonal antibody being developed by GlaxoSmithKline (GSK) for autoimmune diseases. The antibody targets the T cell activation marker LAG-3, which is mainly expressed in inflamed tissues. In GSK's March 2015 Product development pipeline document the antibody is listed under 'Immuno-inflammation' candidates. GSK2831781 entered a Phase I clinical trial in psoriasis early in 2015.clinical trial in psoriasis early in 2015.
|
| http://dbpedia.org/ontology/casNumber
|
2088304-32-7
|
| http://dbpedia.org/ontology/wikiPageID
|
46545835
|
| http://dbpedia.org/ontology/wikiPageLength
|
8822
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1106163780
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Murine +
, http://dbpedia.org/resource/Proof_of_concept +
, http://dbpedia.org/resource/Northwick_Park_Hospital +
, http://dbpedia.org/resource/Fusion_protein +
, http://dbpedia.org/resource/LAG3 +
, http://dbpedia.org/resource/Fragment_crystallizable_region +
, http://dbpedia.org/resource/France +
, http://dbpedia.org/resource/Plaque_psoriasis +
, http://dbpedia.org/resource/Humanized_antibody +
, http://dbpedia.org/resource/T_cell +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/Corticosteroids +
, http://dbpedia.org/resource/LAG-3 +
, http://dbpedia.org/resource/Transplantation_%28journal%29 +
, http://dbpedia.org/resource/Clinical_and_Experimental_Immunology +
, http://dbpedia.org/resource/Cytotoxicity +
, http://dbpedia.org/resource/T_helper_cell +
, http://dbpedia.org/resource/Complement_system +
, http://dbpedia.org/resource/Transplant_rejection +
, http://dbpedia.org/resource/Tuberculin +
, http://dbpedia.org/resource/Medical_literature +
, http://dbpedia.org/resource/Afucosylated_monoclonal_antibodies +
, http://dbpedia.org/resource/University_of_Nantes +
, http://dbpedia.org/resource/BCG_vaccine +
, http://dbpedia.org/resource/Type_IV_hypersensitivity +
, http://dbpedia.org/resource/INSERM +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies +
, http://dbpedia.org/resource/Antibody-dependent_cellular_cytotoxicity +
, http://dbpedia.org/resource/Immunoglobulin_G +
, http://dbpedia.org/resource/IMP731 +
, http://dbpedia.org/resource/PAREXEL +
, http://dbpedia.org/resource/Fr%C3%A9d%C3%A9ric_Triebel +
, http://dbpedia.org/resource/Category:Experimental_drugs +
, http://dbpedia.org/resource/TNF +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Clinical_endpoint +
, http://dbpedia.org/resource/Autoimmune_diseases +
, http://dbpedia.org/resource/Contract_research_organization +
, http://dbpedia.org/resource/Prima_BioMed +
, http://dbpedia.org/resource/Psoriasis +
, http://dbpedia.org/resource/GlaxoSmithKline +
|
| http://dbpedia.org/property/casNumber
|
2088304
|
| http://dbpedia.org/property/legalStatus
|
Investigational
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_drug +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Experimental_drugs +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antibody +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/GSK2831781?oldid=1106163780&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/GSK2831781 +
|
| owl:sameAs |
http://yago-knowledge.org/resource/GSK2831781 +
, http://dbpedia.org/resource/GSK2831781 +
, https://global.dbpedia.org/id/uPZE +
, http://www.wikidata.org/entity/Q19904145 +
, http://rdf.freebase.com/ns/m.0134vzbm +
|
| rdf:type |
http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/MonoclonalAntibody +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
GSK2831781 is a monoclonal antibody being … GSK2831781 is a monoclonal antibody being developed by GlaxoSmithKline (GSK) for autoimmune diseases. The antibody targets the T cell activation marker LAG-3, which is mainly expressed in inflamed tissues. In GSK's March 2015 Product development pipeline document the antibody is listed under 'Immuno-inflammation' candidates. GSK2831781 entered a Phase I clinical trial in psoriasis early in 2015.clinical trial in psoriasis early in 2015.
|
| rdfs:label |
GSK2831781
|
